Project EveryChild
This registry will collect biospecimens and accompanying demographic, epidemiologic, therapeutic, and outcome data from all children diagnosed with cancer at participating Children's Oncology Group institutions, of which Carilion Clinic is one, independent of the patient’s enrollment...
About
Protocol Description
Project EveryChild: A Registry, Eligibility Screening, Biology and Outcome Study
This protocol provides for the collection of biospecimens and accompanying demographic, epidemiologic, therapeutic, and outcome data from all children diagnosed with cancer at participating COG institutions, independent of the patient’s enrollment on a therapeutic clinical trial.
COG# APEC14B1
Eligibility Criteria
Inclusion Criteria
- Patients with a known or suspected neoplasm that occurs in the pediatric, adolescent, or young adult populations are eligible for enrollment as follows:
- All cancer cases with an ICD-O histologic behavior code of two “2” (carcinoma in situ) or three “3” (malignant).
- All neoplastic lesions of the central nervous system regardless of behavior, i.e., benign, borderline, or malignant.
- The following other benign/borderline conditions:
- Mesoblastic nephroma
- Teratomas (mature and immature types)
- Myeloproliferative diseases including transient myeloproliferative disease
- Langerhans cell histiocytosis
- Lymphoproliferative diseases
- Desmoid tumors
- Gonadal stromal cell tumors
- Participants must be ≤ 25 years of age at time of original diagnosis, except for patients who are being screened specifically for eligibility onto a COG (or COG participating NCTN) therapeutic study, for which there is a higher upper age limit.
- Enrollment must occur within 6 months of initial disease presentation OR within 6 months of refractory disease, disease progression, disease recurrence, second or secondary malignancy, or post-mortem.
Exclusion Criteria
-
Not meeting the Inclusion Criteria
Primary Investigator
Dr. Glenn Edwards is the Section Chief of Pediatric Hematology/Oncology, as well as the Children's Oncology Group's Principal Investigator for Carilion Clinic, and has over 30 years of clinical experience. He is board certified by the American Board of Pediatrics in Pediatrics and Pediatric Hematology/Oncology. He completed his Fellowship at Walter Reed Army Medical Center and completed his Internship and Residency at Tripler Army Medical Center.
Contact Information
Contact Information
Wendy McCarty, CCRP
Clinical Research Coordinator II
